Launch Excellence The Latest Addition to Diabetes Treatment: A Deep Dive into Brenzavvy Type 2 diabetes is a chronic disease that affects millions of people worldwide. It is characterized by high levels of sugar in the blood due to the body's cells resisting the normal effect
Launch Excellence Hope for Patients with Anemia of CKD: FDA Approves Jesduvroq GSK plc has announced the FDA approval of Jesduvroq (daprodustat) for the treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.
Launch Excellence The Launch of Amjevita: The First Humira Biosimilar The world of autoimmune treatments has seen a new addition with the launch of Amjevita, the first Humira biosimilar. Humira, the swiss knife medication, has been available in the US since 2002 and
Launch Excellence Empowering a leading biotech manufacturer to make data-backed decisions in the eleventh hour [Case Study] Commercial launches move fast and critical decisions need to be made in a matter of days. See how ZoomRx empowered a leading biotech manufacturer with the necessary insights to make data-backed decisions in real time.
![Empowering a leading biotech manufacturer to make data-backed decisions in the eleventh hour [Case Study]](/content/images/size/w600/2022/09/RT-case---packaging-decisions-01-1.jpg)
